FORMFACTOR INC

Listed Company

FORMCIK 0001039399NasdaqLarge AcceleratedSemiconductors & Related DevicesDelawareFY ends Dec 26

Period

FY 2025

Revenue

$784.99M

Net Income

$54.36M

Total Assets

$1.22B

Equity

$1.04B

Shares Out

77.92M

Op. Cash Flow

$115.40M

Business

FORMFACTOR INC provides electrical and optical test and measurement technologies across the semiconductor product lifecycle, from characterization and modeling to qualification and production test. It designs, manufactures and sells probe cards, analytical probes, probe stations, thermal subsystems, cryogenic systems, and related services including installation, maintenance and application engineering support. Its operations are organized into two reportable segments: the Probe Cards segment (probe cards and analytical probes) and the Systems segment (probe stations, thermal and cryogenic systems). The company sells worldwide through a global direct sales force, manufacturers’ representatives and distributors to semiconductor manufacturers, foundries, fabless companies, research institutions and universities.

Summary from filing dated 2025-02-21

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenues	785	764	663	748	770
Cost of revenues	476	456	405	452	447
Gross profit	309	308	259	296	323
Research and development	116	122	116	109	101
Selling, general and administrative	133	142	133	132	124
Factory start-up costs	3	0	0	—	—
Total operating expenses	252	264	249	241	225
Gain on sale of business	0	21	73	0	0
Operating income	57	65	83	55	98
Interest income	11	14	7	2	569,000
Interest expense	−521,000	−418,000	−421,000	−579,000	−602,000
Other income (expense), net	2	939,000	−285,000	1	495,000
Income before income taxes and equity investment	69	79	89	58	99
Provision for income taxes	13	10	7	7	15
Loss from equity investment	2	0	0	—	—
Net income	54	70	82	51	84
Basic (in USD per share)	0.7	0.9	1.06	0.65	1.08
Diluted (in USD per share)	0.69	0.89	1.05	0.65	1.06
Basic (in shares)	77	77	77	78	78
Diluted (in shares)	78	78	78	78	79

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2023 2023-01-31	FY 2022 2022-12-31
Cash and cash equivalents	103	191	178	—	109
Marketable securities	172	169	151	—	129
Accounts receivable, net	125	104	103	—	88
Inventories, net	111	102	112	—	123
Restricted cash	1	4	1	—	1
Prepaid expenses and other current assets	45	35	30	—	24
Total current assets	557	605	574	—	475
Restricted cash	3	3	2	—	3
Operating lease, right-of-use-assets	17	23	31	—	31
Property, plant and equipment, net of accumulated depreciation	259	210	204	—	190
Equity investment	64	0	—	—	—
Goodwill	216	199	201	—	211
Intangibles, net	16	10	13	—	27
Deferred tax assets	90	92	79	—	68
Other assets	2	4	3	—	4
Total assets	1,224	1,146	1,107	—	1,008
Accounts payable	47	62	64	—	69
Accrued liabilities	48	44	41	—	42
Current portion of term loan, net of unamortized issuance cost of $5 and $5	1	1	1	—	1
Deferred revenue	20	16	17	—	30
Operating lease liabilities	8	8	8	—	7
Total current liabilities	124	131	131	—	150
Term loan, less current portion, net of unamortized issuance cost of $44 and $49	11	12	13	—	14
Deferred tax liabilities	2	0	0	—	3
Long-term operating lease liabilities	12	18	25	—	28
Deferred grant	18	18	18	18	0
Other liabilities	22	19	10	—	6
Total liabilities	189	198	198	—	200
Preferred stock	0	0	0	—	0
Common stock	78,000	77,000	77,000	—	77,000
Additional paid-in capital	864	838	861	—	845
Accumulated other comprehensive loss	−4	−11	−4	—	−6
Accumulated income	175	121	51	—	−31
Total stockholders equity	1,035	948	909	—	808
Total liabilities and stockholders equity	1,224	1,146	1,107	—	1,008

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	38	33	37	29	26
Accretion of discount on investments	−2	−3	−3	182,000	403,000
Reduction in the carrying amount of right-of-use assets	7	7	7	8	7
Stock-based compensation expense	39	40	39	31	29
Deferred income tax provision (benefit)	2	−13	−12	−6	4
Gain on sale of business	−103,000	−21	−73	—	—
Provision for excess and obsolete inventories	15	12	15	25	16
Acquired inventory step-up amortization	0	0	501,000	476,000	723,000
Non-cash restructuring charges	2	428,000	0	200,000	2
Foreign currency transaction losses	2	2	2	2	2
Other than temporary impairment on debt receivable	0	0	1	0	0
Accounts receivable	−20	−2	−23	26	−9
Inventories	−21	−8	−9	−29	−32
Prepaid expenses and other current assets	734,000	546,000	−3	−5	4
Other assets	−483,000	285,000	−146,000	66,000	−326,000
Accounts payable	−6	−8	1	4	−7
Accrued liabilities	5	4	−2	−8	−725,000
Other liabilities	2	10	5	−63,000	285,000
Deferred revenues	4	3	−10	1	2
Deferred grant	0	0	18	0	0
Operating lease liabilities	−8	−7	−8	−8	−7
Net cash provided by operating activities	115	118	65	132	139
Acquisition of property, plant and equipment	−104	−38	−56	−65	−66
Acquisition of business, net of cash acquired	−21	0	0	−3	0
Proceeds from sale of business and assets	103,000	22	102	0	0
Purchase of promissory note receivable	0	−2	0	−1	0
Purchases of marketable securities	−126	−139	−135	−102	−150
Proceeds from maturities and sales of marketable securities	126	124	119	96	92
Net cash provided by (used in) investing activities	−191	−33	29	−76	−125
Proceeds from issuances of common stock	26	10	9	10	11
Purchase of common stock through stock repurchase program, including excise tax paid	−26	−53	−20	−82	−24
Tax withholdings related to net share settlements of equity awards	−12	−20	−11	−16	−21
Payments on term loan	−1	−1	−1	−8	−9
Net cash used in financing activities	−14	−65	−23	−96	−47
Effect of exchange rate changes on cash, cash equivalents and restricted cash	−456,000	−4	−3	−3	−3
Net increase (decrease) in cash, cash equivalents and restricted cash	−90	16	68	−42	−36
Operating lease, right-of-use assets obtained in exchange for lease obligations	954,000	61,000	6	5	12
Increase (decrease) in accounts payable and accrued liabilities related to property, plant and equipment purchases	−11	7	−6	7	3
Cash paid for income taxes, net	9	16	17	11	8
Cash paid for interest	362,000	391,000	422,000	535,000	643,000
Operating cash outflows from operating leases	10	9	9	9	9
Income (Loss) from Equity Method Investments	2	0	0	—	—
Payments to Acquire Equity Method Investments	−67	0	0	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro